North American Menopause Society

Hormone therapy ( HT ) in women with premature ovarian insufficiency or early menopause: Time to think of a new paradigm for healthy aging. A joint FIGO and IMS position paper

Premature ovarian insufficiency (POI) and early menopause (EM) affect millions of women worldwide. Compared with normal menopause, they confer a longer duration of estrogen deficiency and are associated not only with a shorter lifespan, but with a reduced healthspan, owing to an...

Impact of a multi-strain probiotic in real-world women with perimenopause symptoms: a single-arm, virtual pilot study

Perimenopause is characterised by fluctuating ovarian hormones and a heterogeneous, multisystem symptom profile that can substantially impair quality of life (QoL). Non-hormonal management options remain limited for those unable/unwilling to use hormone replacement therapy. Emerg...